(Q38068475)

28 August 2017

1 reference

title

Multitarget ligands in antibacterial research: progress and opportunities (English)

1 reference

28 August 2017

Stephen P East

1

1 reference

28 August 2017

Lynn L Silver

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

19 December 2012

1 reference

Expert Opinion on Drug Discovery

28 August 2017

published in

1 reference

28 August 2017

volume

8

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

143-156

1 reference

Challenges of antibacterial discovery

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Molecular mechanisms that confer antibacterial drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Designed multiple ligands. An emerging drug discovery paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Rational approaches to targeted polypharmacology: creating and navigating protein-ligand interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Combination therapies for combating antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

From magic bullets to designed multiple ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Carbapenems: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Quinolones: action and resistance updated

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Bacterial DNA replication enzymes as targets for antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Antibiotics in the clinical pipeline in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Toprim--a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Selenophene-containing inhibitors of type IIA bacterial topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Type IIA topoisomerase inhibition by a new class of antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Advances in structure-based drug design of novel bacterial topoisomerase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Antimicrobial activity of flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Bacterial cell wall assembly: still an attractive antibacterial target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Peptidoglycan biosynthesis machinery: a rich source of drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Structure, function and dynamics in the mur family of bacterial cell wall ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Dual Inhibitor of MurD and MurE Ligases from Escherichia coli and Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

4-quinolones as noncovalent inhibitors of high molecular mass penicillin-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Structure Guided Development of Potent Reversibly Binding Penicillin Binding Protein Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Structure-guided design of cell wall biosynthesis inhibitors that overcome β-lactam resistance in Staphylococcus aureus (MRSA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Dual targeting antibacterial peptide inhibitor of early lipid A biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

ATP-binding site of bacterial enzymes as a target for antibacterial drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Relating protein pharmacology by ligand chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Selectively nonselective kinase inhibition: striking the right balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

5-Benzylidenethiazolidin-4-ones as Multitarget Inhibitors of Bacterial Mur Ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

Virtual screening for potential inhibitors of bacterial MurC and MurD ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.743991

10.1517/17460441.2013.743991

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference